Assertio Therapeutics Announces Submission of NDA for FDA Approval of Cosyntropin Depot
20 déc. 2018 09h00 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has submitted to the U.S. Food and Drug Administration a 505(b)(2) New Drug...
Assertio Therapeutics Announces Third-Quarter 2018 Financial Results
08 nov. 2018 16h06 HE
|
Assertio Therapeutics, Inc.
-- Confirms Full-Year Net Sales Guidance Range for the Neurology Franchise ---- Raises Full-Year Earnings Guidance and Confirms Adjusted EBITDA Guidance ---- Amends and Strengthens Commercial...
Assertio Therapeutics Announces the Appointment of Daniel A. Peisert as Senior Vice President and Chief Financial Officer; Current CFO Phil B. Donenberg to Retire November 30, 2018
29 oct. 2018 16h05 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that Phillip B. Donenberg, Senior Vice President and Chief Financial Officer, will...
Assertio Therapeutics to Participate in Upcoming Investor Conferences
17 oct. 2018 08h00 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that...
Assertio Therapeutics to Report Third-Quarter 2018 Financial Results After The Close of Markets on Thursday, November 8, 2018
08 oct. 2018 07h00 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release third-quarter 2018 financial results on Thursday, November 8,...
Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference
05 sept. 2018 08h00 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that...
Assertio Therapeutics and Purdue Pharma Settle Patent Infringement Lawsuit
28 août 2018 16h36 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that the Company has entered into a settlement agreement with Purdue Pharma L.P. with...
Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics, Inc.
15 août 2018 06h00 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, has announced that...
Depomed Announces Second-Quarter 2018 Financial Results
08 août 2018 07h30 HE
|
Depomed, Inc.
-- Raises Full-Year Earnings and Adjusted EBITDA Guidance Range and Lowers Full-Year Net Sales Guidance Range for the Neurology Franchise -- -- Confirms Regulatory Plan to File for FDA Approval of...
Depomed to Report Second-Quarter 2018 Financial Results on Wednesday, August 8, 2018
09 juil. 2018 08h30 HE
|
Depomed, Inc.
LAKE FOREST, Ill., July 09, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release second-quarter 2018 financial results on Wednesday, August 8, 2018, before the...